Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The role of Tetraspanin7 in Adipose Tissue Remodeling

ABSTRACT: Tetraspanin7 (Tspan7) is involved in the regulation of body weight, but the detailed mechanisms remain unclear. Here, to reveal the mechanisms, human adipose-derived stem cells were transduced with sh-Tspan7, control-sh, Tspan7-Flag, and Myc-Tspan7 using lentivirus. Following the transduction, adipogenic differentiation was induced and the differentiated adipocytes were characterized by LC-MS/MS.

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Shino Nemoto

PROVIDER: PXD059268 | JPOST Repository | Thu Jan 30 00:00:00 GMT 2025

REPOSITORIES: jPOST

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	001_Nemoto01_250ng_T120SW_B2o5.wiff	Wiff
	001_Nemoto01_250ng_T120SW_B2o5.wiff.scan	Wiff
	001_Nemoto01_250ng_T120_B2o5.wiff	Wiff
	001_Nemoto01_250ng_T120_B2o5.wiff.scan	Wiff
	002_Nemoto02_250ng_T120SW_B2o5.wiff	Wiff

Items per page:

1 - 5 of 20

Similar Datasets

Human subcutaneous adipose tissue and perithyroid adipose tissue gene expression

Project description:Different human adipose tissue depots may have functional differences. Subcutaneous human adipose tissue has been extensively studied, but less is known about other depots. Perithyroid (PT) adipose tissue contains not only white adipocytes but also brown adipocytes. The aim of this study was to compare the expression of brown adipocyte containing perithyroid adipose tissue with s.c. adipose tissue.role in the development of obesity. Expression profiling of adipose tissue may give insights into mechanisms contributing to obesity and obesity-related disorders. Expression analysis of paired biopsies from s.c and perithyriod (PT) adipose tissue from nine subjects undergoing surgery in the thyroid region.

2013-01-22 | E-GEOD-27657 | biostudies-arrayexpress

MicroRNA expression profiling of human adipose stromal cell (hASC) adipogenesis

Project description:Human abdominal adipose tissue was obtained with informed consent from a 33-year old Caucasian female (BMI = 32.96 Kg/m2) undergoing lipoaspiration. Adipose stromal cells (hASCs) were isolated and differentiated into adipocytes in vitro. Two technical replicates from 9 time points relative to induction of adipogenesis (day 0). Also, one sample from pre-adipocytes (day -2) grown without FGF.

2010-09-30 | E-GEOD-20699 | biostudies-arrayexpress

Expression profiling of human adipose stromal cell (hASC) adipogenesis

Project description:Human abdominal adipose tissue was obtained with informed consent from a 33-year old Caucasian female (BMI = 32.96 Kg/m2) undergoing lipoaspiration. Adipose stromal cells (hASCs) were isolated and differentiated into adipocytes in vitro. Two technical replicates from 9 time points realtive to induction of adipogenesis (day 0). Also, two technical replicated from pre-adipocytes (day -2) grown without FGF. Two individual replicates (day 1 and day 7) were removed due to failed hybridizations.

2010-09-30 | E-GEOD-20697 | biostudies-arrayexpress

Human subcutaneous adipose tissue and perithyroid adipose tissue gene expression

2013-01-22 | GSE27657 | GEO

Expression profiling of human adipose stromal cell (hASC) adipogenesis

2010-09-30 | GSE20697 | GEO

MicroRNA expression profiling of human adipose stromal cell (hASC) adipogenesis

2010-09-30 | GSE20699 | GEO

PPARg agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein

Project description:Brown adipose tissue dissipates energy through heat and functions as a defense against cold and obesity. PPARγ ligands have been shown to induce the browning of white adipocytes; however, the underlying mechanisms remain unclear. Here we show that PPARγ ligands require full agonism to induce a brown fat gene program preferentially in subcutaneous white adipose. These effects require expression of PRDM16, a factor that controls the development of classical brown fat. Depletion of PRDM16 blunts the effects of the PPARγ agonist rosiglitazone on the induced brown fat gene program. Conversely, PRDM16 and rosiglitazone synergistically activate the brown fat gene program in vivo. This synergy is tightly associated with an increased accumulation of PRDM16 protein, due in large measure to an increase in the half-life of the protein in agonist treated cells. Identifying compounds that stabilize PRDM16 protein may represent a novel therapeutic pathway for the treatment of obesity and diabetes. Microarray analysis of the differentiated inguinal adipocytes expressing sh-scr or sh-PRDM16 in the presence or absence of rosiglitazone (1uM). These samples were profiled using Affymetrix mouse 430A_2 arrays, representing 2 biological replicates for each samples (8 samples in total).

2012-03-06 | E-GEOD-35011 | biostudies-arrayexpress

Gene expression profile of developing adipose tissue in vivo

Project description:Obesity is characterized by an increase in the size and the number of adipocytes. However, the mechanisms responsible for the formation of adipocytes during development and the molecular mechanisms regulating their increase and maintenance in adulthood are poorly understood. Here, we report the use of leptin-luciferase BAC transgenic mice to track white adipose tissue (WAT) development and guide the isolation and molecular characterization of adipocytes during development using DNA microarrays. These data reveal distinct transcriptional programs that are regulated during murine WAT development in vivo. Developing mouse adipose tissue from at least 3 embryos were pooled for embryonic and postnatal time points.

2011-12-08 | E-GEOD-29502 | biostudies-arrayexpress

Decreased adipocyte-specific Olfactomedin 2 in obesity is a critical driver of defective fat cell cycle and adipose tissue accretion

Project description:Olfactomedin 2 (OLFM2) is a central player in development that also appears to be a critical mediator for energy handling. Here we report that in adipose tissue, expression of OLFM2 is opposite to obesity, being increased upon weight loss. Concurrently, we show steadily increased OLFM2 during adipogenesis, with expression levels reaching its zenith in terminally differentiated adipocytes. Notably, we demonstrate that the loss of this specific olfactomedin domain-containing protein in fat cell progenitors dampens adipogenesis, while the adipogenic conversion is bolstered in engineered 3T3-L1 cells with increased OLFM2. Our seminal findings also bound dwindled expressions of adipocyte-specific OLFM2 to the inflammatory state in the context of obesity, mainly characterized by the influence of macrophage-derived cytokines. Then, we show that the loss of OLFM2 in human adipocytes displays the transient downregulation of genes related to cell cycle, also coupled to deranged energy storage. Next, we transitioned our results to mice models in which whole-body knockout and transcriptionally regulated adipose-specific Olfm2 compel a cluster of molecular changes tightly related to impaired cell cycle (in both) and fat mass accretion (in the later). Current findings unveil the previously unknown expression of OLFM2 in adipocytes and the control of cellular mechanisms related to the obese phenotype exercised by this scaffold protein in adipose tissues.

2023-12-31 | GSE214900 | GEO

Adipose tissue retains an epigenetic memory of obesity after weight loss [snRNAseq]

Project description:Reducing body weight to improve metabolic health and related comorbidities is a primary goal in treating obesity. However, maintaining weight loss is a considerable challenge, especially as the body appears to retain an obesogenic memory that defends against body weight changes. Overcoming this barrier for long-term treatment success is difficult because the molecular mechanisms underpinning this phenomenon remain largely unknown. Here, by using single-nuclei RNA-sequencing, we show that both human and mouse adipose tissue retain cellular transcriptional changes after appreciable weight loss. Furthermore, we find persistent obesity-induced alterations in the mouse adipocyte epigenome, negatively affecting their function and response to metabolic stimuli. Mice carrying this obesogenic memory show accelerated rebound weight gain, and the epigenetic memory can explain future transcriptional deregulation in adipocytes in response to further high-fat diet feeding. In summary, our findings indicate the existence of an obesogenic memory, largely based on stable epigenetic changes, in mouse adipocytes, and likely other cell types. These changes appear to prime cells for pathological responses in an obesogenic environment, contributing to the problematic "yo-yo" effect often seen with dieting. Targeting these changes in the future could improve long-term weight management and health outcomes.

2024-11-14 | GSE236579 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data